Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

AECOM Tops Q2 Earnings, Misses on Revenue, Boosts 2025 View
AECOM Tops Q2 Earnings, Misses on Revenue, Boosts 2025 View

AECOM ACM reported mixed results for second-quarter fiscal 2025, where earnings surpassed the Zacks Consensus Estimate and grew on a year-over-year basis. Revenues missed the consensus mark and

Is the Options Market Predicting a Spike in West Bancorporation Stock?
Is the Options Market Predicting a Spike in West Bancorporation Stock?

Investors in West Bancorporation, Inc. WTBA need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 18, 2025 $35.00 Call had some of the highest

CNA Financial Q1 Earnings Miss Estimates on Poor Underwriting Income
CNA Financial Q1 Earnings Miss Estimates on Poor Underwriting Income

CNA Financial Corporation CNA reported first-quarter 2025 core earnings of $1.03 per share, which missed the Zacks Consensus Estimate by 11.2%. The bottom line decreased 20.7% year over year.The

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Taysha Gene Therapies, Inc. (TSHA) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Vivos Therapeutics, Inc. (VVOS) reports results for the quarter ended March 2025. While this widely-known consensus

Analysts Estimate Perion Network (PERI) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Perion Network (PERI) to Report a Decline in Earnings: What to Look Out for

The market expects Perion Network (PERI) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

On Holding (ONON) Expected to Beat Earnings Estimates: Should You Buy?
On Holding (ONON) Expected to Beat Earnings Estimates: Should You Buy?

The market expects On Holding (ONON) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

The market expects Ovid Therapeutics (OVID) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

The market expects 908 Devices Inc. (MASS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

CyberArk (CYBR) Reports Next Week: Wall Street Expects Earnings Growth
CyberArk (CYBR) Reports Next Week: Wall Street Expects Earnings Growth

CyberArk (CYBR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a

Earnings Preview: Gladstone Investment (GAIN) Q4 Earnings Expected to Decline
Earnings Preview: Gladstone Investment (GAIN) Q4 Earnings Expected to Decline

Gladstone Investment (GAIN) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Under Armour (UAA) Expected to Beat Earnings Estimates: Should You Buy?
Under Armour (UAA) Expected to Beat Earnings Estimates: Should You Buy?

Under Armour (UAA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a

Evolution Petroleum (EPM) Earnings Expected to Grow: Should You Buy?
Evolution Petroleum (EPM) Earnings Expected to Grow: Should You Buy?

Evolution Petroleum (EPM) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Will Cadiz (CDZI) Report Negative Q1 Earnings? What You Should Know
Will Cadiz (CDZI) Report Negative Q1 Earnings? What You Should Know

Cadiz (CDZI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a

CAE (CAE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CAE (CAE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects CAE (CAE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Avino Silver (ASM) Earnings Expected to Grow: Should You Buy?Photo, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Avino Silver (ASM) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Avino Silver (ASM) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Nu Holdings Ltd. (NU) to Report Q1 Results: Wall Street Expects Earnings Growth
Nu Holdings Ltd. (NU) to Report Q1 Results: Wall Street Expects Earnings Growth

Nu Holdings Ltd. (NU) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Waters (WAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Waters (WAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2025, Waters (WAT) reported revenue of $661.71 million, up 3.9% over the same period last year. EPS came in at $2.25, compared to $2.21 in the year-ago quarter.

The

Compared to Estimates, UWM (UWMC) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, UWM (UWMC) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2025, UWM Holdings Corporation (UWMC) reported revenue of $613.37 million, up 7.6% over the same period last year. EPS came in at -$0.23, compared to $0.00 in the

Compared to Estimates, L.B. Foster (FSTR) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, L.B. Foster (FSTR) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2025, L.B. Foster (FSTR) reported revenue of $97.79 million, down 21.3% over the same period last year. EPS came in at -$0.20, compared to $0.08 in the year-ago quarter.

Here's What Key Metrics Tell Us About Expeditors International (EXPD) Q1 Earnings
Here's What Key Metrics Tell Us About Expeditors International (EXPD) Q1 Earnings

For the quarter ended March 2025, Expeditors International (EXPD) reported revenue of $2.67 billion, up 20.8% over the same period last year. EPS came in at $1.47, compared to $1.17 in the year-ago

Best Momentum Stocks to Buy for May 6thPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Best Momentum Stocks to Buy for May 6th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:

MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has a Zacks Rank #1 and

Delving Beyond HSBC's Q1 Earnings: Should You Buy the Stock?
Delving Beyond HSBC's Q1 Earnings: Should You Buy the Stock?

HSBC Holdings HSBC reported first-quarter 2025 results last week. Results benefited from higher adjusted revenues and relatively stable operating expenses. On the other hand, heightened uncertainty

Franklin's April AUM Balance Declines Sequentially on Net Outflows
Franklin's April AUM Balance Declines Sequentially on Net Outflows

Franklin Resources, Inc. BEN reported its preliminary assets under management (AUM) of $1.53 trillion as of April 30, 2025, which decreased marginally from the prior month.

The decline in the AUM

Do Options Traders Know Something About Brookfield Infrastructure Partners Stock We Don't?
Do Options Traders Know Something About Brookfield Infrastructure Partners Stock We Don't?

Investors in Brookfield Infrastructure Partners BIP need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $15.00 Put had some of the